- Home
- LH
as 07-30-2025 4:00pm EST
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 21.8B | IPO Year: | N/A |
| Target Price: | $282.79 | AVG Volume (30 days): | 843.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.07 | EPS Growth: | 72.08 |
| 52 Week Low/High: | $209.38 - $283.47 | Next Earning Date: | 07-24-2025 |
| Revenue: | $13,483,800,000 | Revenue Growth: | 7.98% |
| Revenue Growth (this year): | 10.03% | Revenue Growth (next year): | 4.77% |
Stock Insider Trading Activity of Laboratory Corporation of America Holdings (LH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ANDERSON KERRII B | LH | Director | Jun 11 '25 | Sell | $260.00 | 500 | $130,000.00 | 12,666 | |
| Schechter Adam H | LH | President & CEO | May 12 '25 | Sell | $248.73 | 6,105 | $1,518,496.65 | 98,962 |
Latest Laboratory Corporation of America Holdings News
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
PR Newswire
a month ago
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
MT Newswires
a month ago
Barclays Adjusts Labcorp Price Target to $275 From $250
Simply Wall St.
a month ago
Labcorp Holdings Inc.'s (NYSE:LH) Intrinsic Value Is Potentially 59% Above Its Share Price
StockStory
a month ago
5 Insightful Analyst Questions From Labcorp’s Q1 Earnings Call
Zacks
a month ago
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?
Business Wire
a month ago
GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology
PR Newswire
a month ago
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care
Compare LH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.